Kore Private Wealth’s Voyager Therapeutics VYGR Stock Holding History

Kore Private Wealth’s Portfolio VYGR Stock Details VYGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-750	Closed	-$7K	–	1282
2020 Q1	$7K	Hold	750	–	–	﹤0.01%	755
2019 Q4	$10K	Buy	+750	New	+$10.9K	﹤0.01%	753

Other funds holding VYGR

TGI

TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Kore Private Wealth's VYGR Position: Q2 2020 in Review

Kore Private Wealth sold out of Voyager Therapeutics (VYGR) in Q2 2020, closing a stake of 750 shares — an estimated $7K sold.

Kore Private Wealth first reported a position in VYGR in Q4 2019 and held it in 2 quarters. The position peaked at $10K in Q4 2019. 113 funds tracked by Wall St. Rank hold VYGR as of Q2 2020.

Kore Private Wealth reported no remaining Voyager Therapeutics position as of Q2 2020 after selling out during the quarter.
Kore Private Wealth sold 750 Voyager Therapeutics shares in Q2 2020, an estimated $7K.
Kore Private Wealth first reported a position in Voyager Therapeutics in Q4 2019 and held it in 2 quarters.
Kore Private Wealth's Voyager Therapeutics position peaked at $10K in Q4 2019.
113 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2020.

Based on Kore Private Wealth's 13F filing for Q2 2020, filed 14 Aug 2020.